Champions Oncology Inc.
CSBR | NASDAQ
$4.81
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$4.81
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q1 2027 Jul 31, 2026 | Q4 2026 Apr 30, 2026 | Q3 2026 Jan 31, 2026 | Q2 2026 Oct 31, 2025 | Q1 2026 Jul 31, 2025 | Q4 2025 Apr 30, 2025 | Q3 2025 Jan 31, 2025 | Q2 2025 Oct 31, 2024 | Q1 2025 Jul 31, 2024 | Q4 2024 Apr 30, 2024 | Q3 2024 Jan 31, 2024 | Q2 2024 Oct 31, 2023 | Q1 2024 Jul 31, 2023 | Q4 2023 Apr 30, 2023 | Q3 2023 Jan 31, 2023 | Q2 2023 Oct 31, 2022 | Q1 2023 Jul 31, 2022 | Q4 2022 Apr 30, 2022 | Q3 2022 Jan 31, 2022 | Q2 2022 Oct 31, 2021 | Q1 2022 Jul 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15.23M | 13.84M | 16.56M | 15.04M | 14M | 12.36M | 17.04M | 13.49M | 14.06M | 14M | 12.02M | 11.57M | 12.56M | 13.07M | 12.77M | 14.28M | 13.75M | 12.88M | 13.19M | 11.79M | 11.25M |
Cost of Revenue | 7.85M | 6.81M | 8.83M | 7.26M | 8M | 7.27M | 6.62M | 7.43M | 7.07M | 7.25M | 7.85M | 6.62M | 7.68M | 7.34M | 7.7M | 7.44M | 7.05M | 6.22M | 6.41M | 5.61M | 5.4M |
Gross Profit | 7.38M | 7.03M | 7.73M | 7.77M | 6M | 5.08M | 10.42M | 6.06M | 6.99M | 6.75M | 4.17M | 4.96M | 4.88M | 5.73M | 5.07M | 6.84M | 6.69M | 6.66M | 6.79M | 6.18M | 5.86M |
Operating Income | -409K | -631K | -187K | 185K | -507K | -1.71M | 4.5M | 732K | 1.33M | -271K | -2.58M | -1.96M | -2.55M | -2.52M | -2.46M | 7K | -284K | -311K | 830K | 263K | -175K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -415K | -495K | -237K | 255K | -452K | -1.96M | 4.52M | 739K | 1.33M | -190K | -2.52M | -2.06M | -2.54M | -2.54M | -2.42M | -2K | -302K | -346K | 798K | 289K | -158K |
Net Income | -426K | -729K | -279K | 299K | -466K | -1.84M | 4.5M | 728K | 1.31M | -109K | -2.53M | -2.07M | -2.57M | -2.56M | -2.44M | -16K | -319K | -344K | 787K | 277K | -172K |
Selling & General & Admin | 5.76M | 5.43M | 5.64M | 4.97M | 4.43M | 4.84M | 4.2M | 3.64M | 4.21M | 4.54M | 4.56M | 4.4M | 4.64M | 4.6M | 4.33M | 4.23M | 4.09M | 4.38M | 3.78M | 3.62M | 3.73M |
Research & Development | 2.34M | 2.12M | 2.27M | 2.62M | 2.08M | 1.96M | 1.72M | 1.69M | 1.45M | 2.05M | 2.19M | 2.52M | 2.79M | 2.85M | 3.2M | 2.6M | 2.89M | 2.59M | 2.18M | 2.3M | 2.3M |
Other Expenses | -314K | 111K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 435K | n/a | n/a | n/a | 807K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 7.79M | 7.66M | 7.91M | 7.59M | 6.51M | 6.8M | 5.92M | 5.33M | 5.66M | 7.02M | 6.75M | 6.91M | 7.43M | 8.25M | 7.53M | 6.83M | 6.98M | 6.97M | 5.96M | 5.91M | 6.03M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 3.09M | 2.8M | 2.67M | 2M | 1.86M | 2.31M | 1.81M | 1.75M | 1.68M | 1.78M | 1.8M | 1.8M | 1.7M | 1.85M | 1.76M | 1.7M | 1.69M | 1.62M | 1.55M | 1.64M | 1.57M |
Cost & Expenses | 15.64M | 14.47M | 16.75M | 14.85M | 14.5M | 14.07M | 12.54M | 12.76M | 12.73M | 14.27M | 14.6M | 13.53M | 15.11M | 15.59M | 15.23M | 14.27M | 14.03M | 13.19M | 12.36M | 11.52M | 11.43M |
Income Tax Expense | 11K | 172K | 42K | 18K | 14K | -129K | 23K | 11K | 21K | -81K | 11K | 11K | 28K | 20K | 17K | 14K | 17K | -2K | 11K | 12K | 14K |
Shares Outstanding (Basic) | 13.9M | 13.83M | 13.89M | 13.79M | 13.79M | 13.75M | 13.7M | 13.59M | 13.59M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.55M | 13.53M | 13.52M | 13.28M | 13.5M | 13.43M | 13.4M |
Shares Outstanding (Diluted) | 13.9M | 13.83M | 13.89M | 14.46M | 13.79M | 13.75M | 14.36M | 14.02M | 14.04M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.56M | 13.53M | 13.52M | 13.51M | 14.39M | 14.55M | 13.4M |
EPS (Basic) | -0.03 | -0.05 | -0.02 | 0.02 | -0.03 | -0.13 | 0.33 | 0.05 | 0.10 | -0.01 | -0.19 | -0.15 | -0.19 | -0.19 | -0.18 | 0 | -0.02 | -0.03 | 0.06 | 0.02 | -0.01 |
EPS (Diluted) | -0.03 | -0.05 | -0.02 | 0.02 | -0.03 | -0.13 | 0.31 | 0.05 | 0.09 | -0.01 | -0.19 | -0.15 | -0.19 | -0.19 | -0.18 | 0 | -0.02 | -0.03 | 0.05 | 0.02 | -0.01 |
EBITDA | -95K | -174K | 104K | 612K | -94K | -1.57M | 4.92M | 1.14M | 1.78M | 621K | -2.04M | -1.58M | -2.09M | -1.13M | -1.85M | 558K | 226K | 222K | 1.19M | 635K | 159K |
EBIT | -409K | -495K | -237K | 255K | -452K | -1.96M | 4.52M | 739K | 1.33M | 164K | -2.52M | -2.06M | -2.54M | -1.71M | -2.42M | -2K | -302K | -346K | 798K | 289K | -158K |
Depreciation & Amortization | 314K | 321K | 341K | 357K | 358K | 394K | 398K | 399K | 449K | 457K | 481K | 484K | 445K | 583K | 575K | 560K | 528K | 568K | 396K | 346K | 317K |
Add to Watchlist
Select watchlists to add or remove CSBR